SHCBP1 promotes cisplatin resistance of ovarian cancer through AKT/mTOR/Autophagy pathway
Apoptosis · 2025
DOI: 10.1007/s10495-024-02027-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Apoptosis, 2025. Verfasst von Gonghua Qi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, 107 Wenhua Xi Road, Jinan, 250012, China. Hauptthemen laut MEDLINE: Cisplatin, Drug Resistance, Neoplasm, Ovarian Neoplasms, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Nature Science Foundation of Shandong Province, the Tai-Shan Scholar Program from Shandong Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, 107 Wenhua Xi Road, Jinan, 250012, China.
- Gynecologic Oncology Key Laboratory of Shandong Province, Qilu Hospital, Shandong University, Jinan, 250012, China.
- Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong Province, 250117, China.
- 71217 of the Chinese People's Liberation Army, Laiyang, 265200, China.
- Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, 107 Wenhua Xi Road, Jinan, 250012, China. luoxia@email.sdu.edu.cn.
- Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, 107 Wenhua Xi Road, Jinan, 250012, China. kongbeihua@sdu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Nature Science Foundation of Shandong Province
- the Tai-Shan Scholar Program from Shandong Province
- the Tai‐Shan Scholar Program from Shandong Province
Zitieren
APA
Qi, G., Ma, H., Teng, K., Gai, P., Gong, Y., Chen, J., Luo, X., & Kong, B. (2025). SHCBP1 promotes cisplatin resistance of ovarian cancer through AKT/mTOR/Autophagy pathway. Apoptosis. https://doi.org/10.1007/s10495-024-02027-3
Vancouver
Qi G, Ma H, Teng K, Gai P, Gong Y, Chen J, et al. SHCBP1 promotes cisplatin resistance of ovarian cancer through AKT/mTOR/Autophagy pathway. Apoptosis. 2025. doi:10.1007/s10495-024-02027-3
BibTeX
@article{Qi2025,
author = {Qi, Gonghua and Ma, Hanlin and Teng, Kai and Gai, Panpan and Gong, Yanmin and Chen, Jingying and Luo, Xia and Kong, Beihua},
title = {SHCBP1 promotes cisplatin resistance of ovarian cancer through AKT/mTOR/Autophagy pathway},
journal = {Apoptosis},
year = {2025},
doi = {10.1007/s10495-024-02027-3}
}
EUVIMED